Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.26.4 (
RNase H
)
2,751
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous work from our laboratory demonstrated that
CCAAT/enhancer-binding protein delta
(
C/EBP delta
) functions in the initiation and maintenance of G(0) growth arrest in mouse mammary epithelial cells (MECs). In this report, we investigated the posttranscriptional and posttranslational regulation of
C/EBP delta
in G(0) growth-arrested mouse MECs. The results of transcriptional inhibitor studies demonstrated that the
C/EBP delta
mRNA exhibits a relatively short half-life in G(0) growth-arrested mouse MECs (t(1/2) approximately 35 min). In contrast,
C/EBP delta
mRNA has a longer half-life in G(0) growth-arrested mouse fibroblast cells (t(1/2) >100 min). Oligo/
RNase H
cleavage analysis and rapid amplification of cDNA ends-poly(A) test both confirmed the short
C/EBP delta
mRNA half-life observed in MECs and demonstrated that the
C/EBP delta
mRNA poly(A) tail is relatively short (approximately 100 nucleotides). In addition, the poly(A) tail length was not shortened during
C/EBP delta
mRNA degradation, which suggested a deadenylation-independent pathway. The
C/EBP delta
protein also exhibited a relatively short half-life in G(0) growth-arrested mouse MECs (t(1/2) approximately 120 min). The
C/EBP delta
protein was degraded in a ubiquitin-dependent manner, primarily in the nucleus, during G(0) growth arrest. In conclusion, these studies indicated that the
C/EBP delta
mRNA and protein content are under tight regulation in G(0) growth-arrested mouse MECs, despite the general concept that G(0) growth arrest is associated with a decrease in cellular activity.
...
PMID:Posttranscriptional and posttranslational regulation of C/EBP delta in G0 growth-arrested mammary epithelial cells. 1255 32